Health
Musim Mas Launched Women Smallholders Training Program
An expansion of the group's longstanding Smallholders Program, the first phase covered health and nutrition training; will be expanded to include financial literacy SINGAPORE, Dec. 12, 2023 /PRNewswire/ -- The Musim Mas Group announced the completion of the first phase of its Women Smallholders ...
2023-12-12 16:00
1686
Qilu Pharmaceutical Announces Results from Phase I Clinical Study for Its Novel Bispecific Antibody QLS31905 at ESMO Immuno-Oncology Congress
JINAN, China, Dec. 12, 2023 /PRNewswire/ -- During the ESMO Immuno-Oncology Congress 2023 held inGeneva, Switzerland, from December 6th to 8th, Qilu Pharmaceutical presented the latest results of the Phase I clinical trial for QLS31905 in patients with advanced solid tumors through a poster prese...
2023-12-12 11:04
1946
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium
* ELEVATE and ELECTRA studies were designed with the objective to overcome different treatment resistance mechanisms and enhance patient outcomes with oral-oral combination options. * A preliminary analysis of data in the phase 1b part of the ELEVATE trial demonstrates antitumor activity of t...
2023-12-12 00:42
2753
Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform
Inovalon ONE® Platform seamlessly aggregates, standardizes, and analyzes diverse data to gain meaningful insights, support evidence-based decision-making, and offer data security and privacy. SAN ANTONIO, Dec. 11, 2023 /PRNewswire/ -- Frost & Sullivan recently researched the healthcare analytics...
2023-12-11 22:00
1517
First Patient Dosed in U.S. Expanded Access Program for TLX250-CDx, Telix's Breakthrough Kidney Cancer Imaging Agent
MELBOURNE, Australia and INDIANAPOLIS, Dec. 11, 2023 /PRNewswire/ -- Telix
Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the
first patient has been dosed in aUnited States (U.S.) expanded access program
(EAP, ClinicalTrials.gov ID:NCT06090331
2023-12-11 19:40
1466
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
SAN FRANCISCO and SINGAPORE, Dec. 11, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced the appointment of Angèle Maki, Ph.D., as Chief Business Offi...
2023-12-11 18:00
1636
Global Times: TV drama 'Welcome to Milele' represents decades-old China-Africa medical aid cooperation
BEIJING, Dec. 11, 2023 /PRNewswire/ -- This year marks the 60th anniversary sinceChina sent its first medical team to aid Algeria on April 6, 1963. Over the past six decades, China has dispatched over 30,000 medical professionals to 76 countries and regions across the world. Currently, Chinese m...
2023-12-11 09:01
1530
Antengene Announces the Study of Anti-CD24 Monoclonal Antibody ATG-031 Dosed Its First Patient in the United States
* The Phase I PERFORM trial, taking place at four clinical trial centers across the U.S., will evaluate the safety and preliminary efficacy of ATG-031 in patients withadvanced solid tumors or B-cell non-Hodgkin's lymphoma (B-NHL). * ATG-031, discovered and developed in-house by Antengene, is t...
2023-12-11 08:30
1641
Menarini Group Presents New Progression-Free Survival Data from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Clinically Relevant Subgroups of Patients with ER+, HER2- Metastatic Breast Cancer (mBC) with ESR1 Mutations at SABCS 2023
* This new post hoc analysis of the Phase 3 EMERALD trial evaluated elacestrant in the endocrine-sensitive population (CDK4/6 inhibitor duration of at least 12 months) with tumors harboring ESR1 mutations. * This analysis shows a clinically meaningful improvement in progression-free survivala...
2023-12-08 23:13
3675
RewirEd Summit at COP28 makes history by bringing education to the forefront of climate action to impact billions of children and youth globally
DUBAI, UAE, Dec. 8, 2023 /PRNewswire/ -- RewirEd Summit, the first ever global education summit on climate brought together 1,000 participants, including 2 heads of state, 22 ministers, and 28 CEOs, with 260 speakers from diverse sectors, representing 209 entities and 76 countries, to address urg...
2023-12-08 22:06
2623
C.P. Group and Toyota/Commercial Japan Partnership Technologies achieved new milestones towards decarbonization with multi-faceted solutions across energy, data and mobility
* A joint partnership by Charoen Pokphand Group (C.P. Group), Toyota Motor Corporation (TMC) and Commercial Japan Partnership Technologies (CJPT) announced the successful pilot project for biogas-derived hydrogen production in Thailand. * C.P. Group plans to use such biogas-derived hydrogen fo...
2023-12-08 17:57
2855
Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan
TOKYO, Dec. 8, 2023 /PRNewswire/ -- According to Estimation of the Number of
Patients With Mitochondrial Diseases: A Descriptive Study Using in a nationwide
database inJapan
2023-12-08 13:40
1884
CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma
* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma. * This marks the 13th NDA approval obtained by CSt...
2023-12-08 12:10
5539
CU Medicine study published in The Lancet Infectious Diseases concludes that a novel oral microencapsulated live bacteria consortia (SIM01) alleviates long COVID symptoms
HONG KONG, Dec. 8, 2023 /PRNewswire/ -- A randomised, double-blind, placebo-controlled trial (RECOVERY STUDY) conducted by TheChinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) and Microbiota I-Center (MagIC) showed that an oral microbiome microencapsulated formula (SIM01)...
2023-12-08 10:38
2252
Infinitus Co-organizes 2023 Responsibilities for Health Forum: Fostering Quality and Innovation in Traditional Chinese Medicine
GUANGZHOU, China, Dec. 8, 2023 /PRNewswire/ – The 2023 Responsibilities for Health Forum (RHF) was held onDecember 4th, serving as a major event within the 2023 Boao Forum for Chinese Entrepreneurs. The larger forum took place in Boao, Hainan province from December 2nd to December 5th. Hosted by ...
2023-12-08 09:33
2598
The GBA Healthcare Group and CUHK Medical Centre announce strategic cooperation to jointly build The GBA Integrated Value Based Care Partnership Ecosystem
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Today, CUHK Medical Centre ("CUHKMC") and The GBA Healthcare Group (HK) Limited ("GBAH Group") signed a strategic cooperation agreement, to jointly build The GBA Integrated Value Based Care Partnership Ecosystem. Dr Hong FUNG, Chief Executive Officer of ...
2023-12-07 15:41
2881
Unlocking the Potential of Multi-Omics in Precision Medicine: A Conversation with Kazusa DNA Research Institute
CHIBA, Japan, Dec. 7, 2023 /PRNewswire/ -- The integration of multi-omics approaches offers a comprehensive panorama for advancing our comprehension of biology. It now plays a more important role in understanding the roots of diseases, and in expediting precision medicine and catalyzing advanceme...
2023-12-07 15:37
1883
Herbalife Introduces Array of New Wellness Products Tailored to Needs of Consumers in Asia Pacific
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Herbalife, a global health and wellness company, today announced that during the year to date it has launched 20 unique products (43 product SKUs) inAsia Pacific markets, including formulations specially tailored to the needs of local consumers. The l...
2023-12-07 15:00
3255
Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Valtech Valuation has recently concluded valuations for several projects within the biotechnology and medical technology sector, specifically focusing on genetic engineering. We are honored to have been entrusted with providing valuation opinions to the man...
2023-12-07 10:00
1900
Valtech Provides Biotechnology and Technology Startup Orientated Valuation Support
HONG KONG, Dec. 7, 2023 /PRNewswire/ -- Valtech Valuation has recently concluded valuations for several projects within the biotechnology and medical technology sector, specifically focusing on genetic engineering. We are honored to have been entrusted with providing valuation opinions to the man...
2023-12-07 10:00
4559
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12035
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8090
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
7831
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7248
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5581